WuXi TIDES boosts oligo, peptide offerings due to a rise in demand, with three new builds ongoing
Ings #Ings
BARCELONA — Oligonucleotide and peptide provider WuXi TIDES is increasing its service capacity due to a rise in customers, particularly from biopharma companies that have assets progressing into the clinic, chief business officer Yu Lu said.
WuXi TIDES is expanding its production of oligonucleotides and peptides, as well as its manufacturing of products that use these materials, Lu added on the sidelines of the Convention of Pharmaceutical Ingredients (CPHI) in Barcelona. This includes three new builds and two facility expansions.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.